We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Mobile Spirometer Measures Lung Function Between Physician Visits

By HospiMedica International staff writers
Posted on 16 Jun 2015
A handheld, wireless spirometer enables in-home tracking and monitoring of asthma and chronic obstructive pulmonary disease (COPD). More...


The Cohero Health mobile spirometer assesses critical lung function metrics as precisely as clinical-grade spirometers, including peak flow, forced vital capacity (FVC), and forced expiratory volume (FEV1), thus providing a much more accurate picture of lung health. The mobile spirometer is paired via Bluetooth with a smartphone or tablet, enabling real-time measurement and reporting via the AsthmaHero and BreatheSmart applications. The data can be integrated into clinical workflows, to empower decision making at point of care, or as a long-term patient monitoring tool.

The apps can also deliver customized medication reminders and check medication compliance via proprietary HeroTracker sensors. They can thus track and analyze the effects on lung function of maintenance and rescue medication use, along with external triggers. In conjunction with the mobile spirometer, the integrated, connected healthcare platform can help improve clinical decision making and prevent acute events. The mobile spirometer is a product of Cohero Health (New York, NY, USA).

“We are enhancing respiratory care by recording critical measurements over time, outside of a physician’s office,” said Melissa Manice, PhD, MPH, co-founder and CEO of Cohero Health. “This longitudinal view of changes in lung function over time, in parallel with medication adherence tracking, equips physicians to partner with their patient to make more informed treatment decisions together.”

“The inclusion of a mobile spirometer in our platform allows stakeholders to track, for the first time ever, how patients are using their medication, and how they are responding to their medication, in real time,” added Daniel Weinstein, co-founder and COO of Cohero Health. “Through robust tracking, motivating better behaviors, and early identification of potential acute events, the Cohero Health platform enables better patient management, reduced costs to the healthcare system, and most importantly, healthier patients.”

Related Links:

Cohero Health



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.